Benjamin Zeskind is President and Chief Executive Officer of Immuneering Corp (IMRX). The company reported total compensation of $1,660,612 for fiscal year 2025.
| Salary | $641,493 |
|---|---|
| Bonus | $423,385 |
| Stock awards | $0 |
| Option awards | $579,504 |
| Non-equity incentive plan | $0 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $16,230 |
| Total | $1,660,612 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Immuneering Corp filed April 20, 2026, accession 0001790340-26-000048.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Benjamin Zeskind this page | President and Chief Executive Officer | $1,660,612 |
| Brett Hall | Chief Scientific Officer | $1,289,504 |
| Michael Bookman | Chief Legal Officer | $890,362 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Immuneering Corp compensation brief.
Benjamin Zeskind's compensation sits inside Immuneering Corp's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.